Role of enteroendocrine hormones in appetite and glycemia
Authors:
- 1 May 2021
- journal article
- review article
- Published by Elsevier in Obesity Medicine
- Vol. 23
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K23-DK114460)
- National Institutes of Health (C-Sig P30DK84567)
- American Neurogastroenterology and Motility Society
- Mayo Clinic
This publication has 72 references indexed in Scilit:
- Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese menAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- CholecystokininCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Long-Term Persistence of Hormonal Adaptations to Weight LossNew England Journal of Medicine, 2011
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering TherapiesDiabetes Care, 2010
- Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell SurvivalEndocrinology, 2010
- Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndromeDiabetologia, 2009
- Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administrationClinical Endocrinology, 2006
- CCK enhances response to gastric distension by acting on capsaicin-insensitive vagal afferentsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003